Clinical trial
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
- Lead sponsor
- European Institute of Oncology
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 18, 2025
- Completion date
- December 31, 2027
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer (diagnosis), nsclc